Trial Profile
Study of iron isomaltoside-1000 (Monofer((R)) ) versus ferric carboxy-maltose (Ferinject) in iron deficient anemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Nov 2018
Price :
$35
*
At a glance
- Drugs Ferric derisomaltose (Primary) ; Ferric carboxymaltose
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- 30 Nov 2018 New trial record
- 04 Nov 2018 Results published in the British Journal of Clinical Pharmacology